ADIPOQ and obesity disorder: In addition to lipid overload, glucose intolerance and insulin resistance are associated with obesity, which may be partly explained by reduced serum concentrations of adiponectin (31), an important adipokine that promotes glucose uptake, insulin sensitivity, and β-oxidation in peripheral tissues.